This site is part of the Informa Connect Division of Informa PLC

This site is operated by a business or businesses owned by Informa PLC and all copyright resides with them. Informa PLC's registered office is 5 Howick Place, London SW1P 1WG. Registered in England and Wales. Number 3099067.

Cell & Gene Therapy Manufacturing & Commercialization Europe

Speaking Proposals Due 17th May

  • 00
    Days
  • 00
    Hrs
  • 00
    Mins
  • 00
    Secs
Save the Date: 2-4 December 2024
Convention Centre DublinDublin, Ireland
Interest
Menu
Interest

Ohad Karnieli, Ph.D., MBA
CEO at Adva Biotechnology
Speaker

Profile

A well-known international expert in cell therapy. Dr. Karnieli is the founder and former CEO of Atvio Biotech, a leading Innovation center for cell & gene therapy. Former VP of Technology & Manufacturing at Pluristem Therapeutics, and the former VP of the medical device at Goji solutions. Dr. Karnieli has served as the chair of the process & product development committee of the International Society for Cellular Therapies, an expert member in the ISO TC276 Biotechnology standard committee, and the former chair of the science and technology committee of the Alliance for Regenerative Medicine.

Agenda Sessions

  • Managing Durability of CGT: Communicating Value and Reducing Uncertainty

    , 11:05
    View Session

  • Next Generation bioreactors for manufacturing cell and gene therapies using Continues Adaptive Muli parameter control and AI to achieve increased quality, predictability and reproducibility.

    , 14:15
    View Session

At this event

Prev
Next
Vanessa Kress, PhD
Business Development Manager
CEVEC – now part of Cytiva

See Ohad at Cell & Gene Therapy Manufacturing & Commercialization Europe

Interest